Anti-proteinase 3 (anti-PR3) antibodies are a subtype of anti-neutrophil cytoplasmic antibodies (ANCAs), specifically directed against proteinase 3, a serine protease located in the azurophilic granules of neutrophils and monocytes. Anti-PR3 is most commonly associated with granulomatosis with polyangiitis (GPA), a form of ANCA-associated vasculitis (AAV). These autoantibodies are believed to play a pathogenic role by activating neutrophils, promoting endothelial damage, and contributing to inflammation in small- to medium-sized blood vessels. The presence of anti-PR3 is a key biomarker for diagnosing GPA and can be detected using immunoassays such as ELISA or indirect immunofluorescence.
In clinical settings, anti-PR3 serves not only as a diagnostic tool but also as a prognostic marker. High titers of anti-PR3 are typically correlated with disease activity and may help guide treatment decisions and monitor for relapse. In research contexts, anti-PR3 is studied for its role in the immunopathogenesis of vasculitis and as a potential therapeutic target. Ongoing studies are investigating the mechanisms by which PR3 and its corresponding autoantibodies contribute to immune dysregulation, aiming to develop more targeted immunotherapies for ANCA-associated diseases.
This product is manufactured in Italy by Diametra.
Size | 1 x 96 Well |
Sensitivity | 0.13 AU/mL |
Dynamic Range | 10 – 160 AU/mL |
Incubation Time | 2 hours |
Sample Type | Serum, Plasma |
Immunogen | |
Source Species | |
Specificity | |
Expression System | |
Clone | |
Group | |
Alpha Chain | |
Beta Chain | |
Peptide | |
Peptide Source | |
Format | |
Buffer | |
Concentration | |
Storage | 2-8°C |
Alternative Names | Anti-Proteinase 3, PR3-ANCA, c-ANCA, cytoplasmic ANCA, Anti-serine protease 3 |
Instructions For Use | https://eaglebio.com/wp-content/uploads/2014/06/DCM091_Anti_PR3_c-ANCA_ELISA_Kit_Package_Insert.pdf |
MSDS | https://eaglebio.com/wp-content/uploads/2025/03/DCM091_Anti_PR3_c-ANCA_ELISA_Kit_SDS.pdf |